The microbiota vault initiative: safeguarding Earth's microbial heritage for future generations
- PMID: 40579417
- PMCID: PMC12205078
- DOI: 10.1038/s41467-025-61008-5
The microbiota vault initiative: safeguarding Earth's microbial heritage for future generations
Abstract
Microbial ecosystems are fundamental to planetary and human health, yet human activities are accelerating their loss. Disruptions to microbial communities undermine environmental stability, biodiversity, and health. Urgent action is required to preserve microbial diversity. The Microbiota Vault Initiative provides a global framework to safeguard microbiomes from human, animal, and environmental sources. It proactively archives microbial diversity for future needs, prioritizing depositor sovereignty, equitable collaboration, and ethical governance. By sharing limited information on deposits, the initiative fosters microbial conservation and collaboration between local and global researchers. It complements other efforts to ensure the resilience of microbiomes in an era of rapid environmental change.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: M.G.D.-B., D.S., M.F., A.E., P.V., N.A.B., A.L., C.H., P.Z., A.M., S.S., A.L., S.W.P., J.Z., R.T., C.S., D.A.T., Y.Y.L., V.B., Y.T., M.H., A.K., R.K., J.A.G. and M.J.B. are founders of the initiative and/or participants in the Launch Phase. R.K. is a co-founder of Biota, Inc., and Micronoma, holds equity; he receives income as a consultant or as a scientific advisory board member for BiomeSense, GenCirq, DayTwo, Cybele, Biota, and Micronoma. The University of California, San Diego has reviewed and approved these arrangements in accordance with its conflict of interest policies.
Figures

References
-
- Blaser, M. J. The theory of disappearing microbiota and the epidemics of chronic diseases. Nat. Rev. Immunol.17, 461–463 (2017). - PubMed
-
- Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes.38, 1290 (2014). - PubMed
-
- Bach, J. F. Infections and autoimmune diseases. J. Autoimmun.25, 74–80 (2005). - PubMed
-
- Zimmermann, P., Messina, N., Mohn, W. W., Finlay, B. B. & Curtis, N. Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: a systematic review. J. Allergy Clin. Immunol.143, 467–485 (2019). - PubMed
-
- Bager, F., Madsen, M., Christensen, J. & Aarestrup, F. M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31, 95–112 (1997). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical